Abstract
Periodontitis is a chronic inflammatory condition driven by plaque-associated microorganisms, where uncontrolled bacterial invasion and proliferation impair host immune responses, leading to localized periodontal tissue inflammation and bone destruction. Conventional periodontal therapies face challenges, including incomplete microbial clearance and the rise of antibiotic resistance, limiting their precision and effectiveness in managing periodontitis. Recently, nanotherapies based on polymeric materials have introduced advanced approaches to periodontal antimicrobial therapy through diverse antimicrobial mechanisms. This review explored specific mechanisms, emphasizing the design of polymer-based agents that employ individual or synergistic antimicrobial actions, and evaluated the innovations and limitations of current strategies while forecasting future trends in antimicrobial development for periodontitis.
1 Introduction
As a prevalent biofilm-associated oral disease, periodontitis presents a significant public health concern (Sczepanik et al., 2020). This condition, driven by microbial factors and host responses, leads to gingival inflammation, periodontal pocket formation, and alveolar bone loss, ultimately resulting in tooth loss if untreated (Yuan et al., 2023). Early prevention and intervention are essential to slow disease progression and maintain oral health (Janakiram and Dye, 2020; Pattamatta et al., 2024). The primary periodontal treatment methods—mechanical debridement through scaling and root planning—aim to reduce bacterial load, alleviate inflammation, and inhibit bone loss, but its effectiveness is often limited by difficult-to-reach infection sites (Petersilka et al., 2002; Arweiler et al., 2017). Conventional antibiotics, which inhibit bacterial growth by targeting key biological processes (Saikia and Chetia, 2024), face limitations in periodontitis due to the need for high doses to penetrate biofilms, risking microbiome disruption, fungal overgrowth, allergic reactions, and other adverse effects (Nakajima et al., 2021; Yu et al., 2022; Herrera et al., 2023). Additionally, the rise of antimicrobial resistance—through mechanisms such as efflux pump activation and membrane alteration—further complicates treatment efficacy (Abouelhadid et al., 2020; Klenotic et al., 2020; Darby et al., 2022). These challenges underscore the need for innovative periodontal therapies capable of overcoming resistance and enhancing therapeutic outcomes.
Periodontitis arises primarily from the destructive symbiotic relationship between dental plaque biofilms and the immune system of host (Lamont et al., 2018). The bacterial hydrolysis of proteins and the resulting inflammatory response create an acidic microenvironment that selectively promotes the growth of periodontitis-associated bacteria (Xiu et al., 2022; Hsiao et al., 2014). This cycle of bacterial proliferation leads to the characteristic loss of soft and hard tissue in periodontitis, emphasizing the need for targeted antimicrobial therapies to interrupt this pathological progression (Li et al., 2024). This review focused on the latest therapeutic strategies using polymer-based macromolecular materials to combat periodontitis-associated bacteria. We summarized the primary antimicrobial mechanisms of novel agents for periodontitis treatment and discussed innovative polymeric material designs that leverage these mechanisms. Finally, we addressed the challenges in antimicrobial therapy, offering insights for future developments in the field.
2 Polymer-based antimicrobial strategies
Conventional antibiotics kill bacteria by disrupting bacterial membranes and walls or by interfering with protein synthesis and metabolic processes (Lewis et al., 2024). However, pure drugs are prone to isomerization and degradation in aqueous environments, which diminish their antimicrobial efficacy. To overcome this, complexes are introduced to enhance stability and preserve potency (Lam et al., 2018; Kaupbayeva and Russell, 2020; Haktaniyan and Bradley, 2022). For example, metronidazole (MTZ) has been encapsulated in solid lipid nanoparticles (SLN) or electrostatically spun into triple-layered eccentric side-by-side fibrous structures for controlled release, improving the efficacy of periodontitis treatment (Zhao et al., 2024). Polymeric drug delivery systems enhance the solubility, reduce toxicity, and increase the stability of antimicrobial agents. These systems also enable controlled and programmed drug release in response to specific microenvironmental changes. Critical factors in polymer design, such as particle size, surface charge, hydrophobicity, mucosal adhesion, and targeted ligands, influence the ability to penetrate biofilms and effectively kill bacteria (Huo et al., 2016; Jiang et al., 2023; Ju et al., 2023). Novel antimicrobial polymers are strategically designed to target different bacterial mechanisms, and the combination of multiple mechanisms allows for precise bacterial localization and efficient destruction, offering a promising solution for periodontal therapy (Shi et al., 2021a; Zou et al., 2015; De et al., 2022). Below, we discussed novel antimicrobial strategies involving polymers, categorized by the antimicrobial mechanisms.
2.1 Mechanisms of membrane disruption
Membrane integrity is essential for bacterial survival, and electrostatic interactions are key in disrupting bacterial membranes. Various recognition units—such as antibodies, biomolecules, chemical moieties, and functional nanomaterials—have been developed based on biological and chemical characteristics of bacterial surfaces (Yin et al., 2024). These recognition units fall into two main categories: non-specific recognition and ligand-receptor-specific recognition.
2.1.1 Non-specific recognition based on electrostatic interactions
Distinguished from specific recognition that occurs for specific biomolecules, non-specific recognition usually refers to molecules interacting with each other through non-covalent bonds, such as electrostatic interactions. Electrostatic interactions refer to the attraction or repulsion between charged groups. The main advantage of using non-specific interactions is that spatio-temporal controlled release and precise targeting of drugs can be achieved from an antimicrobial platform, ultimately leading to efficient antimicrobials (Adibnia et al., 2020). Bacterial membrane surfaces are rich in negative charges, primarily due to the extracellular glycosylation of phospholipids and membrane proteins. The interaction between nanomedicines and bacterial membranes is more complex than simple electrostatic attraction. Nanomedicines with different charge characteristics exhibit distinct mechanisms of action and endocytosis pathways. Positively charged nanodrugs selectively interact with negatively charged lipids through electrostatic forces, enhancing adsorption and endocytosis. This process effectively crosses the bacterial membrane, inducing tension that leads to membrane deformation and rupture (Yuan et al., 2020).
Polyamino acids exhibit distinct properties dictated by the structure of their side chains (Shen et al., 2018). Three alternating amino acid copolymers—Orn-Ser, Orn-Gly, and Orn-Val—were synthesized using solid-phase peptide technology. The diverse side chains demonstrated excellent biocompatibility, broad-spectrum antimicrobial activity, and selective antimicrobial properties (Ma et al., 2023). ε-Polylysine, a naturally occurring cationic peptide, exerts potent antimicrobial effects by disrupting bacterial membranes, inducing oxidative stress, and modulating gene expression (Li et al., 2019; Dima et al., 2020; Huang et al., 2024; Rao et al., 2024). To enhance antimicrobial efficacy, a novel double-crowned vesicle system, formed by the co-assembly of two block copolymers (PCL-b-P (Lys-co-Phe) and PEO-b-PCL), was designed for periodontitis treatment. The PEO crown imparted protein-repelling properties, enabling penetration of extracellular polymeric substances in biofilms, while the P(Lys-co-Phe) crown provided positive charge, bacterial membrane penetration, and broad-spectrum antimicrobial effects (Xi et al., 2019).
α-Lipoic acid (LA), a mitochondrial coenzyme, confers antioxidant and anti-inflammatory effects via its disulfide ring structure (Yu et al., 2024). LA reduces oxidative stress and apoptosis by promoting osteogenic marker expression through the NOX4, NF-κB, JNK, and PI3K/AKT pathways, ultimately mitigating periodontal bone loss (Lu et al., 2017b). Additionally, LA induces morphological changes and dysfunction in bacterial membranes to achieve antimicrobial effects (Shi et al., 2016; Mu et al., 2022). Wet-reactive PolyLA-GelMA elastic patches exhibited strong adhesion to gingival tissues through intermolecular interactions, making them suitable for filling periodontal defects and promoting alveolar bone regeneration. In vitro studies confirmed the patches’ excellent hemocompatibility, antibacterial properties, and ROS-scavenging ability (Qi et al., 2024). Gelatin, a natural macromolecular polymer that mimics the extracellular matrix (ECM) and contains RGD sequences, is commonly used to create natural gels. Gelatin methacryloyl (GelMA) hydrogels possess intrinsic antimicrobial properties, which are enhanced by quaternary ammonium groups and glycidyl-trimethylammonium chloride (GTMAC), effectively inhibiting bacterial enzymes, such as gingival protease (Vargas-Alfredo et al., 2022). Natural polyphenol microspheres were innovatively fabricated by combining T-NPs and poloxamer to create a pH- and temperature-sensitive antibiotic delivery platform, enabling in situ slow release of T-NPs at periodontitis lesions. This approach mitigated oxidative stress and inhibited oral pathogenic bacteria (Qi et al., 2022).
The suitability of Chitosan for periodontal applications stems from its exceptional biocompatibility, biodegradability, selective permeability, and antimicrobial activity. The positively charged, low-molecular-weight chitosan binds to negatively charged teichoic acid or lipopolysaccharide through electrostatic interactions, enhancing membrane permeability to exert extracellular antimicrobial effects (Ke et al., 2021). Chitosan oligomers cross bacterial cell wall, inhibiting DNA/RNA transcription, protein synthesis, and mitochondrial function, thus demonstrating intracellular antimicrobial activity (Raafat and Sahl, 2009; Kravanja et al., 2019). Furthermore, chitosan interferes with bacterial copolymerization (Tan et al., 2018). Chemically modified chitosan derivatives exhibit enhanced antimicrobial activity and water solubility. The introduction of quaternary ammonium groups enhances the cationic properties of chitosan and improves its solubility in aqueous and alkaline solutions (Tan et al., 2013). These modifications include the attachment of functional groups bind to anionic sites on microbial membrane surfaces, which not only promotes agglutination and inhibits microbial proliferation, but also disrupts bacterial membranes and leads to leakage of intracellular DNA and RNA, thereby improving antimicrobial efficacy (Murotomi et al., 2023). Diabetic patients are particularly vulnerable to periodontal disease due to the immune system suppression caused by hyperglycemia, necessitating effective antimicrobial solutions. A photo-crosslinked chitosan hydrogel self-regulates the release of therapeutic drugs based on glucose levels, enabling both glucose detection and pH-responsive drug release within the periodontal environment. This system provided a controlled drug delivery mechanism for chitosan (CS)-methacrylamide (CM) formulations (Liu et al., 2019). It is well-established that chitosan modified with quaternary ammonium groups demonstrates superior antimicrobial activity compared to unmodified chitosan. TMC-Lip-DOX nanoparticle, which conjugate quaternary ammonium-modified chitosan (N,N,N-trimethylchitosan) with liposomes and doxycycline, forms a pH-responsive system effective against dental biofilms. The nanoparticle accumulates in acidic environments via electrostatic interactions, penetrate biofilms, degrade extracellular polymers, and enhance doxycycline’s antimicrobial effect, offering a promising strategy for preventing and treating periodontitis (Hu et al., 2019).
To achieve precise antimicrobial effects, introducing a local stimulus-response mechanism into drug delivery systems is a common targeted strategy. Streptococcus lactis peptides, with inherent antimicrobial properties, are encapsulated in sodium caseinate (SC) carriers through strong interactions with anionic alginate molecules. This nanocarrier system not only enhances antimicrobial activity but also promotes biofilm elimination and imparts pH responsiveness (Niaz et al., 2020). Liu et al. developed a novel functional peptide module (FPM) consisting of a short antimicrobial peptide (SAMP) flanked by two anchoring peptides containing arginine protease (Rgp)-specific splice sites. This design uses the gingipain secreted by Porphyromonas gingivalis as a responsive stimulus, resulting in both intense gingipain reactivity and potent inhibition of Porphyromonas gingivalis growth (Liu et al., 2021).
Antimicrobial peptides (AMPs) offer significant advantages over traditional antibiotics in oral antimicrobial therapies. Known for their lysine- and arginine-rich properties, as well as their amphiphilic structures, AMPs inhibit bacterial dehydrogenase activity and disrupt bacterial membranes through electrostatic interactions and hydrogen bonding. This leads to membrane rupture and bacterial cell death (Gao et al., 2023). AMPs also interfere with peptidoglycan synthesis by binding to precursor molecules involved in bacterial cell wall formation or by directly interacting with peptidoglycan and amino acids. In particular, for Gram-negative bacteria, AMPs bind to negatively charged lipopolysaccharides in the outer membrane, forming peptide-lipid complexes that generate transmembrane channels, compromising cell membrane integrity. Additionally, acidic phospholipids in the bacterial membrane interact electrostatically with cationic AMPs, while the hydrophobic regions of the peptides accumulate on the amphiphilic phospholipid surface, further disrupting the membrane structure (Yount and Yeaman, 2013; Luo and Song, 2021).
Plant antimicrobial peptides (PMAMPs) with a circular or hairpin structure exhibit enhanced biofilm penetration and antimicrobial activity when combined with matrix-degrading enzymes. These PMAMPs consist of a green fluorescence protein (GFP)-fusion peptide and the protein drug protegrin-1 (PG-1), which rapidly kill bacteria within 1 h of local exposure at low concentrations. The permeabilization mechanism is primarily driven by changes in bacterial surface charge, PG-1 penetration of the lipid bilayer, and interactions with negatively charged teichoic and lipoteichoic acids (Liu et al., 2016). Arginine-rich β-hairpin peptides self-assemble into hydrogels that lyse bacteria through guanidine-mediated interactions with bacterial membranes, independent of antibiotics. The antimicrobial potency of these hydrogels is significantly increased by higher arginine content. To balance antimicrobial activity with reduced cytotoxicity and hemolysis, the PEP6R peptide was synthesized by substituting an arginine residue in the PEP8R peptide. At a concentration of 1.5 wt%, PEP6R self-assembled into a hydrogel of moderate hardness that effectively eradicated bacteria (Veiga et al., 2012). Lysozyme (LYS) effectively kills Gram-positive bacteria by disrupting the β-1,4-glycosidic bonds in the bacterial cell wall and inducing membrane rupture. However, its activity against Gram-negative bacteria is relatively weak. To enhance both the antimicrobial efficacy and stability of LYS, 2,2-pyridinedicarboxaldehyde (PDA) and the initiator ABM were introduced at the N-terminus of LYS, forming a LYS-PDMAEMA conjugate. This conjugate exhibited superior activity against Gram-positive bacteria of M. lysodeikticus and Gram-negative bacteria of E. coli. The distribution of the red fluorescent Cy5-labeled conjugate on the bacterial surface and within the bacteria highlighted the proposed antibacterial mechanism: the positively charged PDMAEMA disrupts the bacterial membrane and enters the interior through strong multivalent electrostatic interactions with the negatively charged membrane, leading to highly efficient and selective antibacterial effects (Figure 1) (Zhang et al., 2022).
FIGURE 1
2.1.2 Ligand-receptor–based specific recognition
The interactions between immune cells, the complement system, and bacterial surface structures are crucial for pathogen recognition and clearance by the immune system (Rivera et al., 2016; Lu et al., 2017a; Askarian et al., 2018). Porphyromonas gingivalis (P. gingivalis), a Gram-negative anaerobic bacterium, produces a variety of virulent factors that facilitate its adhesion, colonization, and nutrient uptake (Mysak et al., 2014). Porphyromonas gingivalis binds to Toll-like receptors (TLRs) through lipopolysaccharide (LPS) on its surface, triggering an inflammatory signaling cascade and the release of proinflammatory cytokines, ultimately leading to an inflammatory response (Tsukamoto et al., 2018). The virulence factors of P. gingivalis trigger localized inflammation, prompting the host’s immune system to restore periodontal health by primarily producing antibodies and engaging in phagocytosis (Lunar Silva and Cascales, 2021; Blasco-Baque et al., 2017). However, P. gingivalis evades immune surveillance by activating mechanisms that impair immune cell function, particularly macrophages. This ability disrupts the homeostasis between the host and its microbiota, altering the composition of the subgingival biofilm, promoting inflammation, tissue damage, alveolar bone loss, and ultimately leading to periodontal disease.
Porphyromonas gingivalis typically inhibits macrophage phagocytosis and bactericidal activity through TLR2/1 and complement C5a receptor (C5aR)-dependent signaling pathways. In response, researchers developed a microenvironmentally responsive nanogel (MZ@PNM@GCP) that mimics macrophage membranes, achieving a stealth effect. MZ@PNM@GCP specifically targets P. gingivalis through the TLR2/1 complex on the macrophage-mimicking membrane, disrupting the bacterial membrane with cationic nanoparticles and releasing metronidazole inside the bacterial cell. Encapsulating the nanoparticles in a responsive hydrogel allows controlled drug release in localized acidic and inflammatory environments, enhancing treatment efficacy. Additionally, the nanogel prevented P. gingivalis from binding to immune cells, restoring local immune function and targeting pathogenic bacteria. This approach has shown promising results in the prophylactic treatment of periodontitis (Figure 2) (Yan et al., 2022). Innate immune cells utilize TLR4 receptors to detect lipopolysaccharide (LPS) from bacteria, triggering an inflammatory response. Leveraging this TLR4 mechanism, researchers designed a novel nanoplatform (MSNCs) that mimics macrophage membrane properties and expresses TLR4, combining antimicrobial and immunomodulatory effects. By engineering immunocompetent cell membranes, MSNCs selectively localize to bacteria through TLR4 and act as molecular decoys, competitively binding to LPS in the microenvironment (Deng et al., 2023). Actin is a critical component of the cytoskeleton, involved not only in sensing and transmitting mechanical signals but also in macrophage phagocytosis of pathogens. To effectively eliminate P. gingivalis hiding within inactivated immune cells, researchers optimized hydrogel stiffness by adjusting the polyvinyl alcohol (PVA) cross-linking degree. This modification enabled targeted delivery of macrophages and C5a receptor antagonists to the gingival sulcus. At the molecular level, the stiffer hydrogel enhanced the expression of the mechanosensor Piezo1, which translates mechanical stimuli into biochemical responses, such as Rac1 activation and cytoskeletal reorganization, resulting in improved endocytosis and phagocytosis (Figure 3) (Gan et al., 2023).
FIGURE 2
FIGURE 3
The early colonization of the oral cavity by Porphyromonas gingivalis (P. gingivalis) is facilitated by interactions between its secondary hair antigens and oral streptococci, culminating in specific bacterial adhesion. Streptococcus gordonii typically serves as the initial colonizer, using its adhesion proteins to establish a foothold. These proteins provide a nutrient supply and a base for the secondary colonization of P. gingivalis, making Streptococcus gordonii an ideal target for therapeutic interventions. Researchers have engineered surface-modified PLGA nanoparticles (BNP) by incorporating a peptide (BAR) derived from S. gordonii surface proteins. This modification enhanced specific adhesion to P. gingivalis and prevents non-specific bioadhesion, leveraging the bacteria’s known interaction to initiate periodontal infections. This approach aimed to enable multivalent targeting and inhibit bacterial adhesion, as well as the formation of early biofilms (Mahmoud et al., 2019). Similarly, nanoparticles (ZnO2/Fe3O4@MV) were developed by encapsulating ZnO2 within Fe3O4 composite core-shell structures and coating them with S. gordonii membranes. This targeted membrane coating enhances nanoparticle internalization, where the combined action of hydrogen peroxide (H2O2) and hydroxyl radicals disrupts bacterial structures, ultimately leading to bacterial cell death and the removal of symbiotic biofilms (Cao et al., 2023).
The introduction of exogenous substances modulate bacterial subcellular organization by inducing intracellular aggregation through ligand-receptor interactions. This aggregation shows a strong affinity for various proteins, thereby disrupting bacterial contents. A novel method has been proposed for global bacterial disruption, based on DNA-induced intracellular aggregation. This method involved synthesizing dAPM-1, a di-arginine peptide mimetic with a specific spacer linkage, to trigger cellular cohesion through nuclear protein-DNA phase separation. This process disrupted subcellular tissues and induced membrane rupture, interfering with bacterial functions and inhibiting drug resistance (Yang et al., 2024).
2.2 Mechanisms of oxidative damage
Reactive oxygen species (ROS) exert antimicrobial effects primarily through oxidative damage, which undermines bacterial antioxidant defenses. ROS initiate lipid peroxidation by reacting with bacterial membrane lipids, increasing membrane permeability and compromising membrane integrity. This disruption leads to the leakage of bacterial contents and cell death (Elian et al., 2024). The H2O2 produced from ROS interactions with unsaturated fatty acids diffuses within the bacterial cell, interacts with proteins, and facilitates the penetration of metal ions or oxidized molecules, exacerbating lipid peroxidation and accelerating bacterial death (Liu et al., 2022a; Wang et al., 2020). Additionally, ROS oxidatively modify amino acid residues in proteins, altering their structure and function, which leads to protein inactivation. ROS also cause DNA strand breaks and base modifications, resulting in genetic mutations and abnormal gene expression, contributing to bacterial death (Pannunzio and Lieber, 2017; Liang et al., 2019; Srinivas et al., 2019).
Photodynamic therapy (PDT) is a promising bactericidal approach that utilizes photosensitizers to generate reactive oxygen species (ROS) for bacterial eradication (Zhang et al., 2020; Yu et al., 2023). ROS production occurs through two primary pathways: type I and type II (Liu et al., 2022b). The type I pathway generates superoxide anion radicals (O2•−) and hydroxyl radicals (OH•) through electron transfer, while the type II pathway produces singlet oxygen (1O2) through energy transfer between the photosensitizer and oxygen, with H2O2 as an intermediary (Chen et al., 2021). These highly reactive species interact with biological macromolecules, such as purine bases, specific amino acids, and mitochondrial membranes in DNA, resulting in oxidative damage that ultimately causes bacterial cell death (Di Mascio et al., 2019; Ran et al., 2022).
Advancing photosensitizer development is crucial for enhancing antimicrobial effectiveness. Under laser irradiation, the high density of positive charges on the brush layer of star-shaped polycationic brushes (sPDMA) significantly enhanced the binding of the photosensitizer indocyanine green (ICG) to bacterial membranes and its ability to penetrate biofilms. sPDMA@ICG NPs effectively killed Porphyromonas gingivalis, inhibited alveolar bone resorption, and reduced the inflammatory response in both in vivo and in vitro models (Shi et al., 2021b). Inspired by the abalone’s unique suction cup structure, Song et al. employed microfluidic electrospray technology to create a novel, adhesive, light-responsive particle (MP) delivery system for periodontitis treatment. The concave structure of the disc-shaped MPs confers enhanced adhesion and stability in the presence of saliva, while controlled release of minocycline hydrochloride and black phosphorus under near-infrared irradiation provides potent antimicrobial effects against P. gingivalis (Figure 4) (Song et al., 2022). Type I photosensitizers are not constrained by the periodontium’s local anoxic environment, reducing the dependence on oxygen during treatment. In the presence of light, the purine-based C^N ligand in the Ir(III) complex undergoes an n-π* transition, transferring energy to the Ir core and facilitating strong spin-orbit coupling. This mechanism promoted excited state transitions, enhancing the ROS-generating capability of the complex to kill anaerobic bacteria (Ding et al., 2024). An anaerobic cationic polymer (HQRB-SS-Dex) containing the photosensitizer rose Bengal (RB) and dextran, functions through both type I and type II mechanisms. The positively charged quaternary ammonium salts and dextran improved the photosensitizer’s surface adhesion and permeability to bacterial biofilms, particularly against anaerobic periodontal pathogens. The introduction of disulfide bonds significantly improved the biosafety of this complex, making it a promising candidate for clinical treatment of periodontal infections (Qian et al., 2023).
FIGURE 4
Photothermal therapy (PTT) is a hyperthermic treatment that utilizes near-infrared (NIR) light absorbers to generate heat, effectively killing bacteria through laser-induced temperature elevation (Li et al., 2020). The antimicrobial mechanisms of PTT include: (1) the conversion of absorbed light energy into thermal energy by nanomaterials, which rapidly raise the temperature and create a localized high-temperature environment; and (2) the high temperature increasing bacterial cell membrane permeability and directly damaging the bacterial cell wall, facilitating the penetration of antimicrobial drugs or photosensitizers, and leading to cellular content leakage. By designing nanomaterials with specific binding properties to the bacterial surface, PTT enhances therapeutic efficacy while minimizing host cell damage. Moreover, PTT may synergize with antimicrobial agents by promoting immune cell infiltration through thermal effects, thereby boosting the host immune response. Due to its physical mode of action, PTT presents a reduced risk of bacterial resistance, positioning it as a promising antimicrobial strategy, particularly against drug-resistant strains.
Zhang et al. developed an innovative nano-antibiotic delivery system that integrates gold nanocages (GNCs) with two temperature-sensitive components: phase change materials (PCMs) and the heat-sensitive polymer poly (N-isopropylacrylamide-co-bis-diethylaminomethyl methacrylate) (PND). This hybrid system formed a novel, light-triggered antibiotic platform, TC-PCM@GNC-PND. The heat-responsive properties of GNCs enable in situ formation of injectable hydrogels, enhancing local retention of tetracyclines (TCs) after their release at the infection site. Furthermore, the incorporation of positively charged tertiary amine groups in the PND facilitates targeted delivery to negatively charged bacterial surfaces. The efficient photothermal conversion of GNCs induced bacterial damage through heat-mediated membrane disruption and protein denaturation under near-infrared (NIR) irradiation, demonstrating potent antimicrobial activity. This process also triggered phase transitions in the PCM and contraction of the PND, providing precise control over the on-demand release of TCs. In vitro and in vivo studies confirmed the platform’s high bactericidal efficacy and low toxicity, offering valuable insights for the design of new antimicrobial materials (Zhang et al., 2024).
Sonodynamic therapy (SDT) employs ultrasound (US) to activate reactive oxygen species (ROS) generated by acoustic sensitizers, producing toxic effects on a broad spectrum of bacteria. This non-invasive technique offers deep tissue penetration, excellent time precision, and avoids the development of bacterial resistance. A novel acoustic sensitizer was developed by incorporating titanium dioxide (TiO2) onto dendritic mesoporous silica nanoparticles (DLMSNs), reinforcing the structure with silver (DT-Ag) and modifying it with quaternary chitosan (DT-Ag-CS). Upon returning to the ground state, TiO2 transfers energy to oxygen and water, generating ROS that serve as antimicrobial agents. Additionally, the collapse of cavitation bubbles produced localized high temperatures, promoting water pyrolysis and generating more hydroxyl radicals (Xin et al., 2023). This mechanism enhanced the antimicrobial efficacy of the sensitizer. Furthermore, the novel acoustic sensitizer TPP-TeV, a combination of tetraphenylporphyrin and telluric violet alkaloids, produced a substantial number of cationic radicals and ROS through electron transfer under ultrasonic radiation. This effectively killed anaerobic P. gingivalis, improving the local periodontal microbial environment and offering a promising new approach for SDT in the treatment of periodontitis.
The bacterial antioxidant system maintains the balance of ROS levels. When ROS production surpasses the scavenging capacity, oxidative stress ensues, potentially damaging cell membranes and proteins (Redza-Dutordoir and Averill-Bates, 2016). In some cases, dynamic regulation of ROS is essential to preserve physiologically necessary ROS while eliminating cytotoxic ones. For example, on-demand regulation of ROS can be achieved by modulating the surface state of carbon dots, allowing for efficient and precise treatment of chronic inflammation and infection (Nie et al., 2024). As a traditional antimicrobial agent, copper’s contact-killing mechanism plays a critical role in its antimicrobial effect, disrupting bacterial cell membranes. Furthermore, exposure to high concentrations of copper surfaces results in copper ions penetrating the membrane, where they rapidly kill bacteria by impairing respiratory activity and DNA integrity—causing DNA fragmentation and inhibiting respiration (Portelinha et al., 2021; Mahmoudi et al., 2022; Xue et al., 2023). The novel TM/BHT/CuTA hydrogel system integrated antioxidant properties with the antimicrobial activity of tannin-ligated copper nanosheets. This system efficiently delivered therapeutics to inflamed periodontal areas through electrostatic adsorption and physical adhesion. The intelligent release mechanism endowed the material with multiple ROS-scavenging capabilities and robust antimicrobial properties, showing great potential for periodontal treatments (Xinyu et al., 2023). In addition to its direct antimicrobial effects, copper ions generated harmful hydroxyl radicals through a Fenton-like reaction. ROS production not only covalently damages biomolecules but also depletes bacterial antioxidants. To enhance efficacy, amino groups were introduced into mesoporous silica (MSN)-coated citrate-grafted copper sulfide (CuS) nanoparticles (CuS@MSN), imparting a positive charge. These nanoparticles then interacted electrostatically with sulfated chitosan (SCS) to form CuS@MSN-SCS nanoparticles. Cu2+-mediated activation of the ROS signaling pathway enabled efficient bacterial eradication. The initiation of oxidative stress within Fusobacterium nucleatum—including DNA damage, protein oxidation, and lipid peroxidation—induced bacterial apoptosis and biofilm inhibition (Chen et al., 2024).
Nitric oxide (NO) plays a pivotal antimicrobial role in organisms, primarily through the generation of nitroso compounds and the induction of oxidative stress. These reactions disrupt bacterial functions while protecting host cell membranes. Notably, low concentrations of NO, which are not toxic to bacteria, effectively prevent biofilm formation and depolymerize established biofilms via cell signaling mechanisms. Moreover, macromolecule-based NO release systems exhibit superior antimicrobial effects due to enhanced NO loading and stronger binding affinity to bacteria. Under aerobic conditions, NO release significantly boosted the anti-biofilm activity of hyperbranched polymers. This enhancement is evident not only in reduced biofilm metabolic activity but also in the effective killing of bacteria isolated from the biofilm. NO’s excellent aqueous solubility, coupled with its dose-dependent anti-biofilm properties, presents the potential for incorporation into oral rinses, gels, or ointments, opening new avenues for the treatment of oral diseases (Yang et al., 2020).
2.3 Synergistic antibacterial effect
Single antimicrobial mechanism has a certain inhibitory effect against bacteria, but for multiple mechanisms synergistic antimicrobial can overcome the shortcomings of single antimicrobial to achieve more efficient antimicrobial effect. The synergistic antimicrobial action of bacterial membrane disruption and oxidative stress mechanisms against different bacterial targets not only increases the antimicrobial spectrum, but also prolongs the duration of action and reduces the likelihood of bacterial target escape (Hu et al., 2022).
Porphyromonas gingivalis acquires essential iron and heme from hemoglobin through hemagglutinin-mediated erythrocyte aggregation and protease hydrolysis, both crucial for its growth and virulence. Some heme is degraded by P. gingivalis proteases and transported to the bacteria via HmuR or HmuY receptors, while the excess accumulates on the bacterial surface. This excess heme contributes to the bacterium’s oxidative stress resistance through its peroxidase activity (Cao et al., 2024; Olczak et al., 2005; Aleksijević et al., 2022). To exploit this mechanism of adhesion to erythrocytes and heme utilization, Tang et al. engineered GLR (an erythrocyte membrane liposome loaded with gallium porphyrin) nanovesicles mimicking erythrocytes, loaded with gallium porphyrin to target the bacteria. Gallium ions from GLR disrupted bacterial metabolism, while surface-deposited porphyrins generate ROS through photodynamic therapy. This results in a synergistic antimicrobial effect both inside and outside the bacterium through distinct mechanisms (Figure 5A). Additionally, the increased sensitivity to oxygen enhanced antimicrobial effects. SEM revealed that P. gingivalis exhibited stronger adhesion to erythrocytes (Figure 5B). Treatments of P. gingivalis with this material maintained robusted antimicrobial efficacy even at low hydrogen peroxide concentrations, significantly reducing bacterial resistance to oxidative stress. The combination of GLR and photoirradiation (Hv) demonstrated a synergistic antimicrobial effect, effectively eliminating both suspended bacteria and biofilms (Figure 5C). SEM images confirmed the disruption of the bacterial membrane structure by GLR (Figure 5D). In animal studies, the treated rats exhibited a significant reduction in bone resorption, confirming the in vivo antimicrobial efficacy and the practical application potential of this approach (Figure 5E) (Tang et al., 2024).
FIGURE 5
The combination of bacterial membrane disruption, oxidative stress, and antimicrobial mechanisms exhibited enhanced antibacterial and anti-biofilm effects. Surfactin, an amphiphilic biosurfactant derived from Bacillus subtilis, contains a cyclic heptapeptide and β-hydroxy fatty acid structure. Nanoparticles loaded with various concentrations of surfactin inhibited periodontal pathogens and oral bacteria by modifying bacterial membrane hydrophobicity and inducing oxidative stress (Johnson et al., 2020; Johnson et al., 2021). Amphiphilic cationic polymers with guanidine groups readily interact with proteins, nucleic acids, and phospholipids, facilitating deep penetration and efficient bacterial adhesion. A charge reversal strategy temporarily neutralized the positive charge of these polymers to minimize toxicity, while the polymer’s acid-responsive release of the guanidine group reactivates its antimicrobial function when accumulated in biofilms. Upon near-infrared laser irradiation, photothermal agents (CS) encapsulated in the polymer generate heat, effectively eliminating bacterial biofilms.
Similarly, combining various pathways to generate oxidative stress has a more than twofold synergistic effect. Novel Bi2 S3/Cu-TCPP Z-type nanocomposites exhibited superior light absorption and efficient electron-hole separation. Theoretical calculations showed that the heterogeneous structure of Bi2 S3/Cu-TCPP facilitates the adsorption of oxygen molecules and hydroxyl radicals at its interface, enhancing ROS generation. PTT with Bi2S3 nanoparticles promoted Cu2+ ion release, augmenting the chemodynamic therapy (CDT) effect. Moreover, released Cu2+ ions deplete intracellular glutathione, weakening the bacterial antioxidant defense. The combination of PDT/PTT/CDT synergistically enhanced antimicrobial activity against periodontal pathogens and promotes biofilm eradication (Kong et al., 2023). By leveraging the catalytic effects of nano-enzymes and the photosensitization of self-oxygenating PDT materials, Sun et al. developed hybrid nanoplatforms that selectively target anaerobic bacteria, demonstrating exceptional antimicrobial activity and therapeutic selectivity. Additionally, the MnO2 nanolayer was modified to provide a continuous oxygen supply, addressing the challenges posed by the anaerobic microenvironment. This modification alleviated the hypoxic conditions in periodontal pockets and boosts the production of reactive oxygen species (ROS), significantly enhancing the therapeutic efficacy of PDT (Sun et al., 2021).
2.4 Other strategies
Embelin (Emb), a plant-derived compound, was successfully released in a controlled manner using a carboxymethyl chitosan oxidized dextran (CMCS-OD) hydrogel as a drug carrier. This was achieved through a dual dynamic network formed by ligand and Schiff base bonds. Molecular docking studies revealed that Emb interacts with efflux pump proteins, inhibiting their function by hydrogen bonding to their active sites. This interaction reduced the efflux of antimicrobial drugs, thereby influencing bacterial DNA gyrase/topoisomerases. Furthermore, Emb was shown to disrupt bacterial quorum sensing (QS), inhibiting the synthesis of virulence factors and biofilm formation. This reduced bacterial pathogenicity and enhanced the efficacy of antimicrobial drugs, potentially advancing a targeted antimicrobial strategy for the treatment of periodontitis (Cai et al., 2024a).
Bacteria within biofilms are organized in a structured extracellular matrix and interact through quorum sensing (QS) mechanisms. Intercellular communication regulates bacterial behavior and plays a pivotal role in biofilm formation (Bodelón et al., 2016; Su et al., 2023). Co-polymerization among pathogenic bacteria disturb the oral microbiota’s physiological balance, and the proliferation of biofilms is a significant contributor to microbiota dysbiosis. To restore ecological balance, cationic dextran was utilized to induce disruptions in the extracellular polymeric substances (EPS) matrix, promoting phase separation within 2 h and disrupting the matrix’s structural integrity (Li et al., 2023). Furazone C-30 acts as a disruptor of bacterial communication. When combined with Ca2+-coated PLGA particles and PBMP polymers, a novel PLGA/PBMP particle was developed. The sustained release of furazone C-30 from this particle effectively prevented biofilm formation, offering a promising strategy for preventing bacterial infections in periodontitis (Kang et al., 2019).
Probiotics offer a promising approach to address biofilm ecological dysregulation, with their antimicrobial action attributed to direct competition with pathogens for nutrients and adhesion surfaces. Beneficial strains isolated from the oral microbiota of healthy individuals were screened via genome sequencing for genes linked to antimicrobial and immunomodulatory activities, virulence factors, and antibiotic resistance transfer. The selected probiotics target specific periodontal pathogens without exhibiting cytotoxicity (Grilc et al., 2023). The application of oxygen to periodontal tissues exerts a toxic effect on anaerobic pathogens, significantly reducing bacterial colonization in both floating cultures and biofilms. Importantly, this process does not induce side effects or resistance. Oxygen also plays a critical role in energy production and cellular metabolism. Therefore, moderate oxygenation not only inhibits the growth of anaerobic bacteria but also stimulates angiogenesis, cell proliferation, collagen synthesis, and ultimately, periodontal regeneration. Ming et al. developed a biocompatible, oxygen-releasing thermosensitive hydrogel encapsulating small extracellular vesicles (sEVs) and calcium peroxide nanoparticles secreted by bone marrow mesenchymal stem cells (BMMSCs). This system enabled controlled release of sEVs and oxygen, effectively inhibiting the growth of anaerobic periodontal bacteria, alleviating anaerobic infections in periodontal pockets, and promoting the regeneration of periodontal defects (Ming et al., 2024).
3 Conclusions and future perspectives
This review examined polymer-based antibacterial strategies for treating periodontitis. By leveraging various antibacterial mechanisms—either individually or in combination—these strategies reduce the risk of drug resistance, providing insights for the development of future innovative therapies. While polymer-based antimicrobial therapeutics show significant potential in laboratory settings, their clinical efficacy remains to be fully validated. This step is crucial for optimizing and advancing novel therapeutic strategies.
Currently, most antimicrobial treatments for periodontitis focus on eradicating all bacteria within periodontal tissues. However, certain beneficial bacteria, such as lactobacilli and specific streptococci, can counteract or inhibit periodontal disease promoters (Wang et al., 2022). Therefore, developing targeted nanosystems or biomimetic strategies with selective antimicrobial effects is critical. These strategies must protect beneficial flora and normal tissue cells from harm. Given the complex interactions between microbial communities and the immune system, future antimicrobial therapies using nano-delivery systems should aim to restore the oral microbiota’s homeostasis rather than eliminate all microorganisms. Similarly, while current treatments focus on generating ROS to induce oxidative damage, excessive ROS accumulation contributes to periodontal tissue damage. Moderate ROS levels, however, activate c-Jun N-terminal kinase, which in turn activates the transcription factor AP-1 and anti-apoptotic genes, aiding cell survival (Mittal et al., 2014; Tan and Suda, 2018). Thus, maintaining low ROS levels in periodontal tissues is vital for promoting tissue regeneration and optimizing antimicrobial efficacy.
Innovative approaches for periodontitis treatment are advancing rapidly, although most remain in preclinical stages. In vitro and ex vivo models do not fully replicate the complexity of human periodontitis. Combining polymers with drug delivery systems can extend drug residence time in the periodontal pocket and increase local drug concentrations, offering a promising route for clinical application. As effective adjunctive periodontitis therapies, treatments such as photodynamic photothermal are expected to improve periodontal health indicators and reduce the risk of drug resistance when combined with routine periodontal scaling in the clinic, thus creating a more comfortable and convenient periodontitis diagnosis and treatment process (Joshi et al., 2020). Currently, differences in experimental design such as different photosensitizers and laser wavelengths can lead to differences in the clinical indicators of the samples, and there is a need to further standardize the parameters and treatment specifications in order to achieve controlled and visualized efficient diagnosis and treatment (Chiang et al., 2020; Sukumar et al., 2020). Moreover, periodontitis is often associated with a range of comorbidities, including diabetes and hypertension (Bosi et al., 2013; Cai et al., 2024b). Therefore, future antimicrobial therapeutic strategies must consider the treatment of these comorbidities to ensure that new therapies are effective for patients with conditions associated with periodontitis.
Statements
Author contributions
JC: Conceptualization, Visualization, Writing–original draft, Writing–review and editing. SD: Conceptualization, Supervision, Writing–review and editing.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AbouelhadidS.RaynesJ.BuiT.CuccuiJ.WrenB. W.ParkhillJ. (2020). Characterization of posttranslationally modified multidrug efflux pumps reveals an unexpected link between glycosylation and antimicrobial resistance. mBio11. 10.1128/mBio.02604-20
2
AdibniaV.MirbagheriM.SalimiS.DE CrescenzoG.BanquyX. (2020). Nonspecific interactions in biomedical applications. Curr. Opin. Colloid & Interface Sci.47, 70–83. 10.1016/j.cocis.2019.12.004
3
AleksijevićL. H.AleksijevićM.ŠkrlecI.ŠramM.ŠramM.TalapkoJ. (2022). Porphyromonas gingivalis virulence factors and clinical significance in periodontal disease and coronary artery diseases. Pathogens11, 1173. 10.3390/pathogens11101173
4
ArweilerN. B.AuschillT. M.SculeanA. (2017). Patient self‐care of periodontal pocket infections. Periodontology76, 164–179. 10.1111/prd.12152
5
AskarianF.WagnerT.JohannessenM.NizetV. (2018). Staphylococcus aureus modulation of innate immune responses through Toll-like (TLR), (NOD)-like (NLR) and C-type lectin (CLR) receptors. FEMS Microbiol. Rev.42, 656–671. 10.1093/femsre/fuy025
6
Blasco-BaqueV.GaridouL.PomiéC.EscoulaQ.LoubieresP.LE Gall-DavidS.et al (2017). Periodontitis induced byPorphyromonas gingivalisdrives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut66, 872–885. 10.1136/gutjnl-2015-309897
7
BodelóNG.Montes-GarcíAV.LóPEZ-PuenteV.HillE. H.HamonC.Sanz-OrtizM. N.et al (2016). Detection and imaging of quorum sensing in Pseudomonas aeruginosa biofilm communities by surface-enhanced resonance Raman scattering. Nat. Mater.15, 1203–1211. 10.1038/nmat4720
8
BosiE.ScaviniM.CerielloA.CucinottaD.TiengoA.MarinoR.et al (2013). Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care36, 2887–2894. 10.2337/dc13-0092
9
CaiG.RenL.YuJ.JiangS.LiuG.WuS.et al (2024a). A microenvironment‐responsive, controlled release hydrogel delivering embelin to promote bone repair of periodontitis via anti‐infection and osteo‐immune modulation. Adv. Sci.11, e2403786. 10.1002/advs.202403786
10
CaiZ.DUS.ZhaoN.HuangN.YangK.QiL. (2024b). Periodontitis promotes the progression of diabetes mellitus by enhancing autophagy. Heliyon10, e24366. 10.1016/j.heliyon.2024.e24366
11
CaoB.ZhangJ.MaY.WangY.LiY.WangR.et al (2024). Dual‐polymer functionalized melanin‐AgNPs nanocomposite with hydroxyapatite binding ability to penetrate and retain in biofilm sequentially treating periodontitis. Small20, e2400771. 10.1002/smll.202400771
12
CaoQ.XiaoX.TaoC.ShiR.LvR.GuoR.et al (2023). Efficient clearance of periodontitis pathogens by S. gordonii membrane-coated H2O2 self-supplied nanocomposites in a “Jenga” style. Biomaterials Sci.11, 5680–5693. 10.1039/d3bm00641g
13
ChenD.XuQ.WangW.ShaoJ.HuangW.DongX. (2021). Type I photosensitizers revitalizing photodynamic oncotherapy. Small17, e2006742. 10.1002/smll.202006742
14
ChenX.HuangN.WangD.ZhangM.DengX.GuoF.et al (2024). Sulfated chitosan-modified CuS nanocluster: a versatile nanoformulation for simultaneous antibacterial and bone regenerative therapy in periodontitis. ACS Nano18, 14312–14326. 10.1021/acsnano.4c00137
15
ChiangC.-P.HsiehO.TaiW.-C.ChenY.-J.ChangP.-C. (2020). Clinical outcomes of adjunctive indocyanine green-diode lasers therapy for treating refractory periodontitis: a randomized controlled trial with in vitro assessment. J. Formos. Med. Assoc.119, 652–659. 10.1016/j.jfma.2019.08.021
16
DarbyE. M.TrampariE.SiasatP.GayaM. S.AlavI.WebberM. A.et al (2022). Molecular mechanisms of antibiotic resistance revisited. Nat. Rev. Microbiol.21, 280–295. 10.1038/s41579-022-00820-y
17
DengY.RenM.HeP.LiuF.WangX.ZhouC.et al (2023). Genetically engineered cell membrane-coated nanoparticles for antibacterial and immunoregulatory dual-function treatment of ligature-induced periodontitis. Front. Bioeng. Biotechnol.11, 1113367. 10.3389/fbioe.2023.1113367
18
DER.MahataM. K.KimK. T. (2022). Structure‐based varieties of polymeric nanocarriers and influences of their physicochemical properties on drug delivery profiles. Adv. Sci.9, e2105373. 10.1002/advs.202105373
19
DimaS.LeeY.-Y.WatanabeI.ChangW.-J.PanY.-H.TengN.-C. (2020). Antibacterial effect of the natural polymer ε-polylysine against oral pathogens associated with periodontitis and caries. Polymers12, 1218. 10.3390/polym12061218
20
DI MascioP.MartinezG. R.MiyamotoS.RonseinG. E.MedeirosM. H. G.CadetJ. (2019). Singlet molecular oxygen reactions with nucleic acids, lipids, and proteins. Chem. Rev.119, 2043–2086. 10.1021/acs.chemrev.8b00554
21
DingR.LiuX.ZhangW.ChenX.ChenS.YuX.et al (2024). Purine‐based Ir(III) photosensitizers for efficient treatment of periodontal inflammation. Adv. Funct. Mater.34. 10.1002/adfm.202405499
22
ElianC.MéALLETR.VersaceD. L. (2024). Photoactive dye‐loaded polymer materials: a new cutting edge for antibacterial photodynamic therapy. Adv. Funct. Mater.34. 10.1002/adfm.202407228
23
GanZ.XiaoZ.ZhangZ.LiY.LiuC.ChenX.et al (2023). Stiffness-tuned and ROS-sensitive hydrogel incorporating complement C5a receptor antagonist modulates antibacterial activity of macrophages for periodontitis treatment. Bioact. Mater.25, 347–359. 10.1016/j.bioactmat.2023.01.011
24
GaoY.LinH.LuoY.LiJ.GongC.ChenH.et al (2023). Nanomaterial-based photodynamic therapy for antibacterial applications: a comprehensive review. Front. Mater.10. 10.3389/fmats.2023.1260887
25
GrilcN. K.ZidarA.KocbekP.RijavecT.ColjaT.LapanjeA.et al (2023). Nanofibers with genotyped Bacillus strains exhibiting antibacterial and immunomodulatory activity. J. Control. Release355, 371–384. 10.1016/j.jconrel.2023.01.082
26
HaktaniyanM.BradleyM. (2022). Polymers showing intrinsic antimicrobial activity. Chem. Soc. Rev.51, 8584–8611. 10.1039/d2cs00558a
27
HerreraD.VAN WinkelhoffA. J.MatesanzP.LauwensK.TeughelsW. (2023). Europe's contribution to the evaluation of the use of systemic antimicrobials in the treatment of periodontitis. Periodontol. 2000. 10.1111/prd.12492
28
HsiaoC. W.ChenH. L.LiaoZ. X.SureshbabuR.HsiaoH. C.LinS. J.et al (2014). Effective photothermal killing of pathogenic bacteria by using spatially tunable colloidal gels with nano‐localized heating sources. Adv. Funct. Mater.25, 721–728. 10.1002/adfm.201403478
29
HuangJ.TangY.WangP.LiangZ.RenH.ChengZ.et al (2024). A self-transformed N-chlorinated ε-polylysine coating endows titanium implants with programmed integration of robust antibacterial and pro-osteogenic abilities. Chem. Eng. J.493, 152073. 10.1016/j.cej.2024.152073
30
HuF.ZhouZ.XuQ.FanC.WangL.RenH.et al (2019). A novel pH-responsive quaternary ammonium chitosan-liposome nanoparticles for periodontal treatment. Int. J. Biol. Macromol.129, 1113–1119. 10.1016/j.ijbiomac.2018.09.057
31
HuoS.JiangY.GuptaA.JiangZ.LandisR. F.HouS.et al (2016). Fully zwitterionic nanoparticle antimicrobial agents through tuning of core size and ligand structure. ACS Nano10, 8732–8737. 10.1021/acsnano.6b04207
32
HuX.ZhangH.WangY.ShiuB.-C.LinJ.-H.ZhangS.et al (2022). Synergistic antibacterial strategy based on photodynamic therapy: progress and perspectives. Chem. Eng. J.450, 138129. 10.1016/j.cej.2022.138129
33
JanakiramC.DyeB. A. (2020). A public health approach for prevention of periodontal disease. Periodontology84, 202–214. 10.1111/prd.12337
34
JiangW.XuT.SongZ.WangX.YuanS.LiQ.et al (2023). CCL2 is a key regulator and therapeutic target for periodontitis. J. Clin. Periodontology50, 1644–1657. 10.1111/jcpe.13872
35
JohnsonA.HeJ.-L.KongF.HuangY.-C.ThomasS.LinH.-T. V.et al (2020). Surfactin-loaded ĸ-carrageenan oligosaccharides entangled cellulose nanofibers as a versatile vehicle against periodontal pathogens. Int. J. Nanomedicine15, 4021–4047. 10.2147/IJN.S238476
36
JohnsonA.KongF.MiaoS.ThomasS.AnsarS.KongZ.-L. (2021). In-Vitro antibacterial and anti-inflammatory effects of surfactin-loaded nanoparticles for periodontitis treatment. Nanomaterials11, 356. 10.3390/nano11020356
37
JoshiK.BaijuC. S.KhashuH.BansalS. (2020). Clinical effectiveness of indocyanine green mediated antimicrobial photodynamic therapy as an adjunct to scaling root planing in treatment of chronic periodontitis- A randomized controlled clinical trial. Photodiagnosis Photodyn. Ther.29, 101591. 10.1016/j.pdpdt.2019.101591
38
JuY.KimC.-J.CarusoF. (2023). Functional ligand-enabled particle assembly for bio–nano interactions. Accounts Chem. Res.56, 1826–1837. 10.1021/acs.accounts.3c00172
39
KangM.KimS.KimH.SongY.JungD.KangS.et al (2019). Calcium-binding polymer-coated poly(lactide-co-glycolide) microparticles for sustained release of quorum sensing inhibitors to prevent biofilm formation on hydroxyapatite surfaces. ACS Appl. Mater. & Interfaces11, 7686–7694. 10.1021/acsami.8b18301
40
KaupbayevaB.RussellA. J. (2020). Polymer-enhanced biomacromolecules. Prog. Polym. Sci.101, 101194. 10.1016/j.progpolymsci.2019.101194
41
KeC.-L.DengF.-S.ChuangC.-Y.LinC.-H. (2021). Antimicrobial actions and applications of chitosan. Polymers13, 904. 10.3390/polym13060904
42
KlenoticP. A.MosengM. A.MorganC. E.YuE. W. (2020). Structural and functional diversity of resistance–nodulation–cell division transporters. Chem. Rev.121, 5378–5416. 10.1021/acs.chemrev.0c00621
43
KongQ.QiM.LiW.ShiY.SuJ.XiaoS.et al (2023). A novel Z‐scheme heterostructured Bi2S3/Cu‐tcpp nanocomposite with synergistically enhanced therapeutics against bacterial biofilm infections in periodontitis. Small19, e2302547. 10.1002/smll.202302547
44
KravanjaG.PrimožičM.KnezŽ.LeitgebM. (2019). Chitosan-based (Nano)Materials for novel biomedical applications. Molecules24, 1960. 10.3390/molecules24101960
45
LamS. J.WongE. H. H.BoyerC.QiaoG. G. (2018). Antimicrobial polymeric nanoparticles. Prog. Polym. Sci.76, 40–64. 10.1016/j.progpolymsci.2017.07.007
46
LamontR. J.KooH.HajishengallisG. (2018). The oral microbiota: dynamic communities and host interactions. Nat. Rev. Microbiol.16, 745–759. 10.1038/s41579-018-0089-x
47
LewisK.LeeR. E.BröTZ-OesterheltH.HillerS.RodninaM. V.SchneiderT.et al (2024). Sophisticated natural products as antibiotics. Nature632, 39–49. 10.1038/s41586-024-07530-w
48
LiangY.DongB.PangN.HuJ. (2019). ROS generation and DNA damage contribute to abamectin-induced cytotoxicity in mouse macrophage cells. Chemosphere234, 328–337. 10.1016/j.chemosphere.2019.06.031
49
LiJ.WangY.TangM.ZhangC.FeiY.LiM.et al (2024). New insights into nanotherapeutics for periodontitis: a triple concerto of antimicrobial activity, immunomodulation and periodontium regeneration. J. Nanobiotechnology22, 19. 10.1186/s12951-023-02261-y
50
LiT.WenC.DongY.LiD.LiuM.WangZ.et al (2019). Effect of ε-polylysine addition on κ-carrageenan gel properties: rheology, water mobility, thermal stability and microstructure. Food Hydrocoll.95, 212–218. 10.1016/j.foodhyd.2019.04.027
51
LiuJ.XiaoY.WangX.HuangL.ChenY.BaoC. (2019). Glucose-sensitive delivery of metronidazole by using a photo-crosslinked chitosan hydrogel film to inhibit Porphyromonas gingivalis proliferation. Int. J. Biol. Macromol.122, 19–28. 10.1016/j.ijbiomac.2018.09.202
52
LiuM.ChenY.GuoY.YuanH.CuiT.YaoS.et al (2022a). Golgi apparatus-targeted aggregation-induced emission luminogens for effective cancer photodynamic therapy. Nat. Commun.13, 2179. 10.1038/s41467-022-29872-7
53
LiuS.WangY.-N.MaB.ShaoJ.LiuH.GeS. (2021). Gingipain-responsive thermosensitive hydrogel loaded with SDF-1 facilitates in situ periodontal tissue regeneration. ACS Appl. Mater. & Interfaces13, 36880–36893. 10.1021/acsami.1c08855
54
LiuS.WangB.YuY.LiuY.ZhuangZ.ZhaoZ.et al (2022b). Cationization-enhanced type I and type II ROS generation for photodynamic treatment of drug-resistant bacteria. ACS Nano16, 9130–9141. 10.1021/acsnano.2c01206
55
LiuY.KameshA. C.XiaoY.SunV.HayesM.DaniellH.et al (2016). Topical delivery of low-cost protein drug candidates made in chloroplasts for biofilm disruption and uptake by oral epithelial cells. Biomaterials105, 156–166. 10.1016/j.biomaterials.2016.07.042
56
LiX.LovellJ. F.YoonJ.ChenX. (2020). Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat. Rev. Clin. Oncol.17, 657–674. 10.1038/s41571-020-0410-2
57
LiY.XingZ.WangS.WangY.WangZ.DongL. (2023). Disruption of biofilms in periodontal disease through the induction of phase transition by cationic dextrans. Acta Biomater.158, 759–768. 10.1016/j.actbio.2023.01.008
58
LuL. L.SuscovichT. J.FortuneS. M.AlterG. (2017a). Beyond binding: antibody effector functions in infectious diseases. Nat. Rev. Immunol.18, 46–61. 10.1038/nri.2017.106
59
LuS.-Y.WangC.-Y.JinY.MengQ.LiuQ.LiuZ.-H.et al (2017b). The osteogenesis-promoting effects of alpha-lipoic acid against glucocorticoid-induced osteoporosis through the NOX4, NF-kappaB, JNK and PI3K/AKT pathways. Sci. Rep.7, 3331. 10.1038/s41598-017-03187-w
60
Lunar SilvaI.CascalesE. (2021). Molecular strategies underlying Porphyromonas gingivalis virulence. J. Mol. Biol.433, 166836. 10.1016/j.jmb.2021.166836
61
LuoY.SongY. (2021). Mechanism of antimicrobial peptides: antimicrobial, anti-inflammatory and antibiofilm activities. Int. J. Mol. Sci.22, 11401. 10.3390/ijms222111401
62
MahmoudM. Y.Steinbach-RankinsJ. M.DemuthD. R. (2019). Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis. J. Control. Release297, 3–13. 10.1016/j.jconrel.2019.01.036
63
MahmoudiP.AkbarpourM. R.LakehH. B.JingF.HadidiM. R.AkhavanB. (2022). Antibacterial Ti–Cu implants: a critical review on mechanisms of action. Mater. Today Bio17, 100447. 10.1016/j.mtbio.2022.100447
64
MaJ.ShaoM.MaN.LiuJ.TangY.QuW.et al (2023). Alkaline amino acid alternating copolymers with potent antibacterial properties for the treatment of periodontitis. ACS Appl. Polym. Mater.5, 3643–3652. 10.1021/acsapm.3c00309
65
MingL.QuY.WangZ.DongL.LiY.LiuF.et al (2024). Small extracellular vesicles laden oxygen-releasing thermosensitive hydrogel for enhanced antibacterial therapy against anaerobe-induced periodontitis alveolar bone defect. ACS Biomaterials Sci. & Eng.10, 932–945. 10.1021/acsbiomaterials.3c00493
66
MittalM.SiddiquiM. R.TranK.ReddyS. P.MalikA. B. (2014). Reactive oxygen species in inflammation and tissue injury. Antioxidants & Redox Signal.20, 1126–1167. 10.1089/ars.2012.5149
67
MurotomiK.UmenoA.ShichiriM.TanitoM.YoshidaY. (2023). Significance of singlet oxygen molecule in pathologies. Int. J. Mol. Sci.24, 2739. 10.3390/ijms24032739
68
MuS.ZhuY.WangY.QuS.HuangY.ZhengL.et al (2022). Cationic polysaccharide conjugates as antibiotic adjuvants resensitize multidrug‐resistant bacteria and prevent resistance. Adv. Mater.34, e2204065. 10.1002/adma.202204065
69
MysakJ.PodzimekS.SommerovaP.Lyuya-MiY.BartovaJ.JanatovaT.et al (2014). Porphyromonas gingivalis: major periodontopathic pathogen overview. J. Immunol. Res.2014, 476068–8. 10.1155/2014/476068
70
NakajimaM.TannerE. E. L.NakajimaN.IbsenK. N.MitragotriS. (2021). Topical treatment of periodontitis using an iongel. Biomaterials276, 121069. 10.1016/j.biomaterials.2021.121069
71
NiazT.ShabbirS.NoorT.AbbasiR.ImranM. (2020). Alginate-caseinate based pH-responsive nano-coacervates to combat resistant bacterial biofilms in oral cavity. Int. J. Biol. Macromol.156, 1366–1380. 10.1016/j.ijbiomac.2019.11.177
72
NieR.ZhangJ.JiaQ.LiY.TaoW.QinG.et al (2024). Structurally oriented carbon dots as ROS nanomodulators for dynamic chronic inflammation and infection elimination. ACS Nano18, 22055–22070. 10.1021/acsnano.4c05266
73
OlczakT.SimpsonW.LiuX.GencoC. A. (2005). Iron and heme utilization inPorphyromonas gingivalis. FEMS Microbiol. Rev.29, 119–144. 10.1016/j.femsre.2004.09.001
74
PannunzioN. R.LieberM. R. (2017). AID and reactive oxygen species can induce DNA breaks within human chromosomal translocation fragile zones. Mol. Cell68, 901–912. 10.1016/j.molcel.2017.11.011
75
PattamattaM.ChappleI.ListlS.2024. The value‐for money of preventing and managing periodontitis: opportunities and challenges. Periodontology 2000.
76
PetersilkaG. J.EhmkeB.FlemmigT. F. (2002). Antimicrobial effects of mechanical debridement. Periodontology28, 56–71. 10.1034/j.1600-0757.2002.280103.x
77
PortelinhaJ.DuayS. S.YuS. I.HeilemannK.LibardoM. D. J.JulianoS. A.et al (2021). Antimicrobial peptides and copper(II) ions: novel therapeutic opportunities. Chem. Rev.121, 2648–2712. 10.1021/acs.chemrev.0c00921
78
QianY.SunY.ZhangL.ZhuY.LiN.DongF.et al (2023). Oxygen‐free polycationic photosensitizers for treatment of periodontal inflammation. Adv. Funct. Mater.34. 10.1002/adfm.202310636
79
QiY.XuC.ZhangZ.ZhangQ.XuZ.ZhaoX.et al (2024). Wet environment-induced adhesion and softening of coenzyme-based polymer elastic patch for treating periodontitis. Bioact. Mater.35, 259–273. 10.1016/j.bioactmat.2024.02.002
80
QiY.YangJ.ChiY.WenP.WangZ.YuS.et al (2022). Natural polyphenol self-assembled pH-responsive nanoparticles loaded into reversible hydrogel to inhibit oral bacterial activity. Mol. Biomed.3, 28. 10.1186/s43556-022-00082-3
81
RaafatD.SahlH. G. (2009). Chitosan and its antimicrobial potential – a critical literature survey. Microb. Biotechnol.2, 186–201. 10.1111/j.1751-7915.2008.00080.x
82
RanB.RanL.HouJ.PengX. (2022). Incorporating boron into niobic acid nanosheets enables generation of multiple reactive oxygen species for superior antibacterial action. Small18, e2107333. 10.1002/smll.202107333
83
RaoS.-Q.ZhangR.-Y.GaoX.-R.WuL.ZhangY.WangZ.-R.et al (2024). Formation mechanism, environmental stability and antibacterial activity of succinylated ovalbumin/ε-polylysine nanogel loaded with thymol: the synergistic roles of succinylation modification and ε-polylysine. Industrial Crops Prod.220, 119192. 10.1016/j.indcrop.2024.119192
84
Redza-DutordoirM.Averill-BatesD. A. (2016). Activation of apoptosis signalling pathways by reactive oxygen species. Biochimica Biophysica Acta (BBA) - Mol. Cell Res.1863, 2977–2992. 10.1016/j.bbamcr.2016.09.012
85
RiveraA.SiracusaM. C.YapG. S.GauseW. C. (2016). Innate cell communication kick-starts pathogen-specific immunity. Nat. Immunol.17, 356–363. 10.1038/ni.3375
86
SaikiaS.ChetiaP. (2024). Antibiotics: from mechanism of action to resistance and beyond. Indian J. Microbiol.64, 821–845. 10.1007/s12088-024-01285-8
87
SczepanikF. S. C.GrossiM. L.CasatiM.GoldbergM.GlogauerM.FineN.et al (2020). Periodontitis is an inflammatory disease of oxidative stress: we should treat it that way. Periodontology84, 45–68. 10.1111/prd.12342
88
ShenW.HeP.XiaoC.ChenX. (2018). From antimicrobial peptides to antimicrobial poly(α‐amino acid)s. Adv. Healthc. Mater.7, e1800354. 10.1002/adhm.201800354
89
ShiC.ReillyL. T.Phani KumarV. S.CoileM. W.NicholsonS. R.BroadbeltL. J.et al (2021a). Design principles for intrinsically circular polymers with tunable properties. Chem7, 2896–2912. 10.1016/j.chempr.2021.10.004
90
ShiC.SunY.ZhangX.ZhengZ.YangM.BenH.et al (2016). Antimicrobial effect of lipoic acid against Cronobacter sakazakii. Food control.59, 352–358. 10.1016/j.foodcont.2015.05.041
91
ShiE.BaiL.MaoL.WangH.YangX.WangY.et al (2021b). Self-assembled nanoparticles containing photosensitizer and polycationic brush for synergistic photothermal and photodynamic therapy against periodontitis. J. Nanobiotechnology19, 413. 10.1186/s12951-021-01114-w
92
SongC.HuangD.ZhaoC.ZhaoY. (2022). Abalone‐inspired adhesive and photo‐responsive microparticle delivery systems for periodontal drug therapy. Adv. Sci.9, e2202829. 10.1002/advs.202202829
93
SrinivasU. S.TanB. W. Q.VellayappanB. A.JeyasekharanA. D. (2019). ROS and the DNA damage response in cancer. Redox Biol.25, 101084. 10.1016/j.redox.2018.101084
94
SukumarK.TadepalliA.ParthasarathyH.PonnaiyanD. (2020). Evaluation of combined efficacy of photodynamic therapy using indocyanine green photosensitizer and non-surgical periodontal therapy on clinical and microbial parameters in the management of chronic periodontitis subjects: a randomized split-mouth design. Photodiagnosis Photodyn. Ther.31, 101949. 10.1016/j.pdpdt.2020.101949
95
SunX.SunJ.SunY.LiC.FangJ.ZhangT.et al (2021). Oxygen self‐sufficient nanoplatform for enhanced and selective antibacterial photodynamic therapy against anaerobe‐induced periodontal disease. Adv. Funct. Mater.31. 10.1002/adfm.202101040
96
SuY.XuM.-Y.CuiY.ChenR.-Z.XieL.-X.ZhangJ.-X.et al (2023). Bacterial quorum sensing orchestrates longitudinal interactions to shape microbiota assembly. Microbiome11, 241. 10.1186/s40168-023-01699-4
97
TanD. Q.SudaT. (2018). Reactive oxygen species and mitochondrial homeostasis as regulators of stem cell fate and function. Antioxidants & Redox Signal.29, 149–168. 10.1089/ars.2017.7273
98
TangY.QiY.ChenY.WangY.-Q.ZhangC.SunY.et al (2024). Erythrocyte-mimicking nanovesicle targeting Porphyromonas gingivalis for periodontitis. ACS Nano18, 21077–21090. 10.1021/acsnano.4c02316
99
TanH.MaR.LinC.LiuZ.TangT. (2013). Quaternized chitosan as an antimicrobial agent: antimicrobial activity, mechanism of action and biomedical applications in orthopedics. Int. J. Mol. Sci.14, 1854–1869. 10.3390/ijms14011854
100
TanY.LeonhardM.MaS.MoserD.Schneider-SticklerB. (2018). Efficacy of carboxymethyl chitosan against Candida tropicalis and Staphylococcus epidermidis monomicrobial and polymicrobial biofilms. Int. J. Biol. Macromol.110, 150–156. 10.1016/j.ijbiomac.2017.08.094
101
TsukamotoH.TakeuchiS.KubotaK.KobayashiY.KozakaiS.UkaiI.et al (2018). Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1–IKKϵ–IRF3 axis activation. J. Biol. Chem.293, 10186–10201. 10.1074/jbc.M117.796631
102
Vargas-AlfredoN.Munar-BestardM.RamisJ. M.MonjoM. (2022). Synthesis and modification of gelatin methacryloyl (GelMA) with antibacterial quaternary groups and its potential for periodontal applications. Gels8, 630. 10.3390/gels8100630
103
VeigaA. S.SinthuvanichC.GasparD.FranquelimH. G.CastanhoM. A. R. B.SchneiderJ. P. (2012). Arginine-rich self-assembling peptides as potent antibacterial gels. Biomaterials33, 8907–8916. 10.1016/j.biomaterials.2012.08.046
104
WangC.ZhaoP.JiangD.YangG.XueY.TangZ.et al (2020). In situ catalytic reaction for solving the aggregation of hydrophobic photosensitizers in tumor. ACS Appl. Mater. & Interfaces12, 5624–5632. 10.1021/acsami.9b21589
105
WangJ.LiuY.WangW.MaJ.ZhangM.LuX.et al (2022). The rationale and potential for using Lactobacillus in the management of periodontitis. J. Microbiol.60, 355–363. 10.1007/s12275-022-1514-4
106
XinY.GuoZ.MaA.ShiE.LiZ.LiangZ.et al (2023). A robust ROS generation nanoplatform combating periodontitis via sonodynamic/chemodynamic combination therapy. Chem. Eng. J.451, 138782. 10.1016/j.cej.2022.138782
107
XinyuS.LingX.WenjieZ. (2023). Biomimetic synthesis and optimization of extracellular vesicles for bone regeneration. J. Control. Release355, 18–41. 10.1016/j.jconrel.2023.01.057
108
XiuW.WanL.YangK.LiX.YuwenL.DongH.et al (2022). Potentiating hypoxic microenvironment for antibiotic activation by photodynamic therapy to combat bacterial biofilm infections. Nat. Commun.13, 3875. 10.1038/s41467-022-31479-x
109
XIY.WangY.GaoJ.XiaoY.DUJ. (2019). Dual corona vesicles with intrinsic antibacterial and enhanced antibiotic delivery capabilities for effective treatment of biofilm-induced periodontitis. ACS Nano13, 13645–13657. 10.1021/acsnano.9b03237
110
XueY.ZhangL.ZhouJ.ChenJ.MaY.HanY. (2023). Low‐dose Cu ions assisted by mild thermal stimulus inducing bacterial cuproptosis‐like death for antibiosis and biointegration. Adv. Funct. Mater.34. 10.1002/adfm.202308197
111
YangA.SongJ.LiJ.LiY.BaiS.ZhouC.et al (2024). Ligand–receptor interaction-induced intracellular phase separation: a global disruption strategy for resistance-free lethality of pathogenic bacteria. J. Am. Chem. Soc.146, 23121–23137. 10.1021/jacs.4c04749
112
YangL.TelesF.GongW.DuaS. A.MartinL.SchoenfischM. H. (2020). Antibacterial action of nitric oxide-releasing hyperbranched polymers against ex vivo dental biofilms. Dent. Mater.36, 635–644. 10.1016/j.dental.2020.03.012
113
YanN.XuJ.LiuG.MaC.BaoL.CongY.et al (2022). Penetrating macrophage-based nanoformulation for periodontitis treatment. ACS Nano16, 18253–18265. 10.1021/acsnano.2c05923
114
YinX.ShanJ.DouL.ChengY.LiuS.HassanR. Y. A.et al (2024). Multiple bacteria recognition mechanisms and their applications. Coord. Chem. Rev.517, 216025. 10.1016/j.ccr.2024.216025
115
YountN. Y.YeamanM. R. (2013). Peptide antimicrobials: cell wall as a bacterial target. Ann. N. Y. Acad. Sci.1277, 127–138. 10.1111/nyas.12005
116
YuanM.YangY.LiY.YanZ.LinC.ChenJ. (2020). Mucin-like domain of mucosal addressin cell adhesion molecule-1 facilitates integrin α4β7-mediated cell adhesion through electrostatic repulsion. Front. Cell Dev. Biol.8, 603148. 10.3389/fcell.2020.603148
117
YuanX.ZhouF.WangH.XuX.XuS.ZhangC.et al (2023). Systemic antibiotics increase microbiota pathogenicity and oral bone loss. Int. J. Oral Sci.15, 4. 10.1038/s41368-022-00212-1
118
YuQ.FangZ.LuanS.WangL.ShiH. (2024). Biological applications of lipoic acid-based polymers: an old material with new promise. J. Mater. Chem. B12, 4574–4583. 10.1039/d4tb00581c
119
YuY.ChengY.TanL.LiuX.LiZ.ZhengY.et al (2022). Theory-screened MOF-based single-atom catalysts for facile and effective therapy of biofilm-induced periodontitis. Chem. Eng. J.431, 133279. 10.1016/j.cej.2021.133279
120
YuY.SunH.LuQ.SunJ.ZhangP.ZengL.et al (2023). Hypoxic preconditioned MSCs-derived small extracellular vesicles for photoreceptor protection in retinal degeneration. J. Nanobiotechnology21, 449. 10.1186/s12951-023-02225-2
121
ZhangL.WangY.WangC.HeM.WanJ.WeiY.et al (2024). Correction to “light-activable on-demand release of nano-antibiotic platforms for precise synergy of thermochemotherapy on periodontitis”. ACS Appl. Mater. & Interfaces16, 30609–30610. 10.1021/acsami.4c08187
122
ZhangT.AnW.SunJ.DuanF.ShaoZ.ZhangF.et al (2022). N-terminal lysozyme conjugation to a cationic polymer enhances antimicrobial activity and overcomes antimicrobial resistance. Nano Lett.22, 8294–8303. 10.1021/acs.nanolett.2c03160
123
ZhangY.ChengY.YangF.YuanZ.WeiW.LuH.et al (2020). Near-infrared triggered Ti3C2/g-C3N4 heterostructure for mitochondria-targeting multimode photodynamic therapy combined photothermal therapy. Nano Today34, 100919. 10.1016/j.nantod.2020.100919
124
ZhaoP.ZhouK.XiaY.QianC.YuD.-G.XieY.et al (2024). Electrospun trilayer eccentric Janus nanofibers for a combined treatment of periodontitis. Adv. Fiber Mater.6, 1053–1073. 10.1007/s42765-024-00397-6
125
ZouH.WangZ.FengM. (2015). Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery. J. Control. Release214, 121–133. 10.1016/j.jconrel.2015.07.014
Summary
Keywords
antimicrobial, polymer, periodontitis, nanotherapies, mechanisms
Citation
Chen J and Dong S (2025) Polymer-based antimicrobial strategies for periodontitis. Front. Pharmacol. 15:1533964. doi: 10.3389/fphar.2024.1533964
Received
25 November 2024
Accepted
16 December 2024
Published
06 January 2025
Volume
15 - 2024
Edited by
Wenliang Li, Jilin Medical University, China
Reviewed by
Ruogu Qi, Nanjing University of Chinese Medicine, China
Yilong Cheng, Xi’an Jiaotong University, China
Dong Ma, Jinan University, China
Updates
Copyright
© 2025 Chen and Dong.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shujun Dong, dsj@jlu.edu.cn
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.